Associated Papers
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer.
Clarke PA et al.
Oncogene, 2019
Rational design of non-resistant targeted cancer therapies.
Martínez-Jiménez F et al.
Scientific Reports, 2017
ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.
Goetz EM et al.
Cancer Research, 2014
Select a paper to view details